MyAverix Finance
HK · Healthcare
Beijing Tong Ren Tang Chinese Medicine Co Ltd (3613)
Drug Manufacturers - Specialty & Generic
Beijing Tong Ren Tang Chinese Medicine Co Ltd (3613) is listed on HK in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-05-21, reported market cap is $5.97B, P/E ratio is 15.17, net margin is 26.3%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 3613
Beijing Tong Ren Tang Chinese Medicine Co Ltd (3613) — FAQ
What is Beijing Tong Ren Tang Chinese Medicine Co Ltd's market cap?
Beijing Tong Ren Tang Chinese Medicine Co Ltd (3613) has a reported market cap of $5.97B (data as of 2026-05-21).
What is 3613's P/E ratio?
The price-to-earnings (P/E) ratio for Beijing Tong Ren Tang Chinese Medicine Co Ltd (3613) is 15.17 (data as of 2026-05-21).
Does Beijing Tong Ren Tang Chinese Medicine Co Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Beijing Tong Ren Tang Chinese Medicine Co Ltd (3613). Check the MyAverix Finance app for the latest dividend data.
What sector is Beijing Tong Ren Tang Chinese Medicine Co Ltd in?
Beijing Tong Ren Tang Chinese Medicine Co Ltd (3613) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is 3613 listed on?
3613 is listed on HK.
What is Beijing Tong Ren Tang Chinese Medicine Co Ltd's net margin?
Beijing Tong Ren Tang Chinese Medicine Co Ltd (3613) reports a net margin of 26.3% (data as of 2026-05-21).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.